Fluxum

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1988-2012
012319882012

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
BACKGROUND Optimal doses and duration of low-molecular-weight heparin (LMWH) for the treatment of superficial vein thrombosis… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2009
2009
Heparin is an injectable anticoagulant that prevents coagulation. There are presently high and low molecular heparins as well as… (More)
Is this relevant?
Review
2008
Review
2008
Parnaparin (Fluxum) is a low molecular weight heparin (LMWH) that is effective and generally well tolerated in the prevention of… (More)
Is this relevant?
Review
2001
Review
2001
OBJECTIVE To understand the diagnostic and therapeutic status of acute pulmonary embolism in China. METHODS Clinical data of… (More)
Is this relevant?
1993
1993
The prophylactic deep venous antithrombotic efficacy of a low molecular weight heparin (LMWH) was compared with traditional… (More)
Is this relevant?
1992
1992
The efficacy of two treatment protocols with a low molecular weight heparin used for the prevention of post-operative deep vein… (More)
Is this relevant?
1990
1990
Alteration of antithrombin III (ATIII) activity, glycemia level dependent, exists in diabetes mellitus. In this study the ability… (More)
Is this relevant?
1989
1989
In Leriche's "maladie post-operatoire" one of the most frequent and dangerous complications is the deep vein thrombosis (DVT). In… (More)
Is this relevant?
1988
1988
A multicentric study was carried out involving six italian departments of general surgery to assess the efficacy of a low… (More)
Is this relevant?
1988
1988
Seventy seven patients affected by postphlebitic syndrome (PPS) during acute inflammatory and/or obstructive complications were… (More)
Is this relevant?